Holen Sie sich die Stockscreener-App
70.09
2.46%
-1.77
Handel nachbörslich:
70.10
0.010
+0.01%
Schlusskurs vom Vortag:
$71.86
Offen:
$71.45
24-Stunden-Volumen:
1.08M
Relative Volume:
1.23
Marktkapitalisierung:
$3.85B
Einnahmen:
$1.39B
Nettoeinkommen (Verlust:
$-242.49M
KGV:
-15.66
EPS:
-4.4759
Netto-Cashflow:
$173.29M
1W Leistung:
+18.66%
1M Leistung:
+11.64%
6M Leistung:
+33.05%
1J Leistung:
+59.08%
1-Tages-Spanne:
$69.17
$72.78
1-Wochen-Bereich:
$56.44
$72.78
52-Wochen-Spanne:
$41.02
$72.78
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
70.09 | 3.95B | 1.39B | -242.49M | 173.29M | -4.4759 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval - Yahoo Finance
LivaNova PLC 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LIVN) 2026-05-08 - Seeking Alpha
LivaNova PLC (LIVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
LivaNova stock hits 52-week high at 71.97 USD - Investing.com
LivaNova stock hits 52-week high at 71.97 USD By Investing.com - Investing.com Canada
Active Implantable Medical Devices Market Size is Anticipated - openPR.com
LIVN Maintained by Baird -- Price Target Lowered to $76.00 - GuruFocus
LIVN Maintained by Mizuho -- Price Target Raised to $90.00 - GuruFocus
LivaNova (LIVN) Q1 2025 Earnings Transcript - AOL.com
Q1 2026 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC (NASDAQ:LIVN) Q1 2026 Earnings Call Transcript - Insider Monkey
LivaNova Q1 2026 slides: double-digit growth drives guidance raise By Investing.com - Investing.com Australia
LivaNova revenue up 14.3% to USD 362.3M in Q1 2026 - Medical Buyer
LivaNova: Q1 Earnings Snapshot - theheraldreview.com
LivaNova (LIVN) Profit Return And 33.8x P E Test Bullish Narratives - Sahm
LivaNova (LIVN) Q1 2026 Earnings Transcript - AOL.com
LivaNova (LIVN) Q2 2025 Earnings Transcript - AOL.com
LivaNova PLC Lifts Guidance After Strong Q1 Call - TipRanks
LivaNova PLC Q1 2026 Earnings Call Summary - Yahoo Finance
LivaNova (LIVN) Q3 2025 Earnings Transcript - AOL.com
LivaNova Q1 Earnings Call Highlights - Yahoo Finance
LivaNova PLC 1Q 2026: Revenue $362.26M, EPS $0.4— 10-Q Summary - TradingView
LivaNova (NASDAQ: LIVN) returns to profit as Q1 2026 revenue climbs - Stock Titan
LivaNova Q1 2026 slides: double-digit growth drives guidance raise - Investing.com
Earnings call transcript: LivaNova PLC beats Q1 2026 estimates, shares rise - Investing.com
LivaNova Q1 Adjusted Earnings, Revenue Rise; Raises 2026 Adjusted Earnings Guidance - marketscreener.com
LivaNova Q1 2026 Earnings Call Transcript - Benzinga
LivaNova Releases Q1 2026 Financial Results - AlphaStreet
LivaNova (LIVN) beats quarterly expectations but shares slip on cautious guidance reaction - Yahoo Finance
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Earnings Flash (LIVN) LivaNova PLC Reports Q1 Revenue $362.3M, vs. FactSet Est of $346.1M - marketscreener.com
Earnings Flash (LIVN) LivaNova PLC Posts Q1 Adjusted EPS $0.98 per Share, vs. FactSet Est of $0.90 - marketscreener.com
LivaNova beats estimates but shares fall 2% on guidance concerns By Investing.com - Investing.com Nigeria
LivaNova beats estimates but shares fall 2% on guidance concerns - Investing.com UK
LivaNova plc (LIVN) Tops Q1 EPS by 8c, Beats on Revenue; Offers FY26 EPS Guidance - StreetInsider
LivaNova (NASDAQ: LIVN) boosts 2026 outlook on double-digit Q1 growth - Stock Titan
LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance - Business Wire
MSN Money - MSN
LivaNova earnings ahead as reimbursement tailwinds build - Investing.com UK
LivaNova earnings ahead as reimbursement tailwinds build By Investing.com - Investing.com Australia
LIVN SEC FilingsLivanova Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Avoiding Lag: Real-Time Signals in (LIVN) Movement - Stock Traders Daily
LivaNova (LIVN) Projected to Post Earnings on Wednesday - MarketBeat
LivaNova PLC (LIVN) Shares Fall 3.3% -- GF Value Says Still Over - GuruFocus
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):